发明授权
- 专利标题: Human antibodies that bind human TNFα
- 专利标题(中): 结合人TNFα的人抗体
-
申请号: US13466892申请日: 2012-05-08
-
公开(公告)号: US08372401B2公开(公告)日: 2013-02-12
- 发明人: Jochen G. Salfeld , Deborah J. Allen , Hendricus R. J. M. Hoogenboom , Zehra Kaymakcalan , Boris Labkovsky , John A. Mankovich , Brian T. McGuinness , Andrew J. Roberts , Paul Sakorafas , David Schoenhaut , Tristan J. Vaughan , Michael White , Alison J. Wilton
- 申请人: Jochen G. Salfeld , Deborah J. Allen , Hendricus R. J. M. Hoogenboom , Zehra Kaymakcalan , Boris Labkovsky , John A. Mankovich , Brian T. McGuinness , Andrew J. Roberts , Paul Sakorafas , David Schoenhaut , Tristan J. Vaughan , Michael White , Alison J. Wilton
- 申请人地址: BM Hamilton
- 专利权人: Abbott Biotechnology Ltd.
- 当前专利权人: Abbott Biotechnology Ltd.
- 当前专利权人地址: BM Hamilton
- 代理机构: McCarter & English, LLP
- 代理商 Cristin H. Cowles
- 主分类号: A61K39/395
- IPC分类号: A61K39/395 ; C07K16/00
摘要:
Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα) are disclosed. These antibodies have high affinity for hTNFα (e.g., Kd=10−8 M or less), a slow off rate for hTNFα dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize hTNFα activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNFα and for inhibiting hTNFα activity, e.g., in a human subject suffering from a disorder in which hTNFα activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
公开/授权文献
- US20120219564A1 Human Antibodies That Bind Human TNFalpha 公开/授权日:2012-08-30
信息查询